FORUM ON EMERGING INFECTIONS

JOSHUA LEDERBERG (Chair), Sackler Foundation Scholar, The Rockefeller University, New York, New York

VINCENT I. AHONKHAI, Vice President and Director, Anti-Infectives and Biologicals, SmithKline Beecham Corporation, Collegeville, Pennsylvania

STEVEN J. BRICKNER, Manager of Medicinal Chemistry, Central Research Division, Pfizer, Inc., Groton, Connecticut

GAIL H. CASSELL, Vice President for Infectious Diseases Research, Drug Discovery Research, and Clinical Investigation, Eli Lilly & Company, Indianapolis, Indiana

GARY CHRISTOPHERSON, Principal Deputy Assistant Secretary for Health Affairs and Senior Advisor for Force Health Protection, U.S. Department of Defense Reserve Affairs, Washington, D.C.

GORDON H. DeFRIESE, Director and Professor of Social Medicine, Epidemiology, Health Policy, and Administration, Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, North Carolina

CEDRIC E. DUMONT, Medical Director, Office of Medical Services, U.S. Department of State, Washington, D.C.

JESSE GOODMAN, Acting Deputy Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Washington, D.C.

RENU GUPTA, Head of U.S. Research and Development, and Head of Global Cardiovascular, Metabolic, and Endocrine G.I Disorders, Novartis Pharmaceuticals, East Hanover, New Jersey

MARGARET A. HAMBURG, Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, Washington, D.C.

CAROLE A. HEILMAN, Director, Division of Microbiology and Infectious Disease, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

JAMES M. HUGHES, Assistant Surgeon General, and Director, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

SAMUEL L. KATZ, Wilburt C. Davison Professor, Department of Pediatrics, Duke University Medical Center; Undersecretary for Health, Veterans Health Administration, U.S. Department of Veterans Affairs, Washington, D.C.

MARCELLE LAYTON, Bureau of Communicable Diseases, New York City Department of Health, New York, New York

CARLOS LOPEZ, Research Fellow, Research Acquisitions, Eli Lilly Research Laboratories, Indianapolis, Indiana

STEPHEN S. MORSE, Professor of Epidemiology, Columbia University School of Public Health, New York, New York

MICHAEL T. OSTERHOLM, Chairman and Chief Executive Officer, Infectious Control Advisory Network, Eden Prairie, Minnesota

MARC RUBIN, Vice President of Infectious Diseases Therapeutic Development Group, Glaxo Wellcome, Research Triangle Park, North Carolina

DAVID M. SHLAES, Vice President, Infectious Disease Research, Wyeth-Ayerst Research, Pearl River, New York.

JANET SHOEMAKER, Director, Public Affairs, American Society for Microbiology, Washington, D.C.

JOHN D. SIEGFRIED, Deputy Vice-President, Science and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America, Washington, D.C.

P. FREDERICK SPARLING, Chair of Medicine, University of North Carolina at Chapel Hill, and President, Infectious Diseases Society of America, Washington, D.C.

C. DOUGLAS WEBB, JR., Senior Medical Director, Infectious Diseases Global Marketing, Bristol-Myers Squibb, Princeton, New Jersey

CATHERINE E. WOTEKI, Undersecretary for Food and Safety, U.S. Department of Agriculture, Washington, D.C.

Liaisons to the Forum

ENRIQUETA C. BOND, President, Burroughs Wellcome Fund, Morrisville, North Carolina

NANCY CARTER-FOSTER, Director, Program for Emerging Infections and HIV/AIDS, U.S. Department of State, Washington, D.C.

PATRICK W. KELLEY, Colonel, U.S. Army, and Director, Division of Preventive Medicine, Walter Reed Army Institute of Research, Washington, D.C.

EDWARD MCSWEEGAN, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

STEPHEN M. OSTROFF, Acting Deputy Director, and Associate Director for Epidemiologic Science, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

GARY ROSELLE, Program Director for Infectious Disease, Veterans Health Administration, U.S. Department of Veterans Affairs, Cincinnati, Ohio

JAMES M. SIGG, Contract Liaison Officer, Office of Management and Contracts, Centers for Biologics Evaluation and Research, U.S. Food and Drug Administration, Washington, D.C.

FRED TENOVER, Chief, Nosocomial Pathogens Laboratory Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

KAYE WACHSMUTH, Deputy Administrator, Office of Public Health and Science, Food Safety Inspection Service, U.S. Department of Agriculture, Washington, D.C.

Study Staff

JONATHAN R. DAVIS, Senior Program Officer

VIVIAN P. NOLAN, Research Associate

NICOLE AMADO, Project Assistant

THELMA COX, Project Assistant

KATHI HANNA, Consultant

MICHAEL HAYES, Copy Editor

Division Staff

JUDITH R. BALE, Director, Board on Global Health

ANDREW M. POPE, Director, Board on Health Sciences Policy

SARAH PITLUCK, Research Assistant

ALDEN CHANG, Project Assistant

ANDREA L. COHEN, Financial Associate

CARLOS GABRIEL, Financial Associate